Skip to main content
Clinical Trials/CTRI/2018/03/012510
CTRI/2018/03/012510RecruitingPhase 2

Randomized Controlled Trial to compare efficacy of Decongestive CompressionTherapy and injection Benzathine Penicillin G vs Decongestive CompressionTherapy, injection Benzathine Penicillin - G and Placement of Hydrophobic Siliconetube in upper limb Lymphedema following ALND in breast cancer.

Department of surgical disciplines AIIMS NEW DELHI1 site in 1 country128 target enrollmentStarted: February 10, 2017Last updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
128
Locations
1
Primary Endpoint
Improvement in upper limb lymphedema that will be assessed by clinical finding of decreasing limb

Study Overview

Brief Summary

Lymhedema is unavoidable complication post ALND in breast cancer. Staganation of lymph takes place in the arm, with the result, the arm becomes heavy which decreases the movement at joints and deteriorates the quality of life.

Standard of treatment at present is Decongestive Compression Therapy which helps the patient to some extent only. Alternate ways of therapy are being explored that will evacuate the lymph from the lymphedema arm,

resulting in decrease in volume and limb girth, and therefore improve their quality of life. So this is an attempt to use silicone tubes as a artificial lymphatic for drainage of lymph to be placed surgically from dorsum of the hand

to scapular region (Non lymphedema area).

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
20.00 Year(s) to 70.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • All operated cases of breast cancer with established upper limb lymphedema of stage 2 and 3 coming to surgery OPD between May 2017 to Dec 2018 will be recruited after proper screening.

Exclusion Criteria

  • Pre operative difference of >2cm in both upper limbs circumference if documented .
  • Upper limb swelling because of deep vein thrombosis
  • Peripheral arterial disease with involvement of upper limb.
  • Refusals for consent.
  • Known allergy to Penicillin.

Outcomes

Primary Outcomes

Improvement in upper limb lymphedema that will be assessed by clinical finding of decreasing limb

Time Frame: Baseline, 1 month, 3 months, and 6 months of the follow up | period.

girth by measuring with tap along the length of arm every 5 cm and volume measurement by water displacement menthod

Time Frame: Baseline, 1 month, 3 months, and 6 months of the follow up | period.

Secondary Outcomes

  • 1. Improvement in range of movement of shoulder- assessed by degree of pain free movement using(a goniometer .)

Investigators

Sponsor
Department of surgical disciplines AIIMS NEW DELHI
Sponsor Class
Research institution

Study Sites (1)

Loading locations...

Similar Trials

treatment of huge swelling of arm by using... | Clinical Trial